- Record: found
- Abstract: not found
- Article: not found
Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN Clinical Practice Guidelines for diagnosis and treatment
K. Govaerts ,
R.J. Lurvink ,
I.H.J.T. De Hingh ,
K. Van der Speeten ,
L. Villeneuve ,
S. Kusamura ,
V. Kepenekian ,
M. Deraco ,
O. Glehen ,
B.J. Moran ,
Pedro Barrios-Sanchez ,
Joel M. Baumgartner ,
Almog Ben-Yaacov ,
Rosella Bertulli ,
Peter Cashin ,
Tom Cecil ,
Sanjeev Dayal ,
Michele De Simone ,
Jason M. Foster ,
Diane Goere ,
Kuno Lehmann ,
Yan Li ,
Brian W. Loggie ,
Faheez Mohamed ,
David L. Morris ,
Aviram Nissan ,
Pompiliu Piso ,
Marc Pocard ,
Beate Rau ,
Marc A. Reymond ,
Lucas Sideris ,
John D. Spiliotis ,
Paul H. Sugarbaker ,
Victor J. Verwaal ,
Malcom S. Wilson ,
Yutaka Yonemura ,
Yang Yu
February 2020
February 2020
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
<p class="first" id="d893276e185">Pseudomyxoma Peritonei (PMP) is a rare peritoneal
malignancy, most commonly originating
from a perforated epithelial tumour of the appendix. Given its rarity, randomized
controlled trials on treatment strategies are lacking, nor likely to be performed
in the foreseeable future. However, many questions regarding the management of appendiceal
tumours, especially when accompanied by PMP, remain unanswered. This consensus statement
was initiated by members of the Peritoneal Surface Oncology Group International (PSOGI)
Executive Committee as part of a global advisory role in the management of uncommon
peritoneal malignancies. The manuscript concerns an overview and analysis of the literature
on mucinous appendiceal tumours with, or without, PMP. Recommendations are provided
based on three Delphi voting rounds with GRADE-based questions amongst a panel of
80 worldwide PMP experts.
</p>